This inventor holds 1 USPTO granted patent. Top assignees: Korea Basic Science Institute, Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. , University Of Louisville Research Foundation, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2023
Title: The Innovative Contributions of Donghan Lee
Introduction
Donghan Lee is a notable inventor based in Louisville, KY (US). He has made significant contributions to the field of medical science, particularly in methods that enhance platelet counts in subjects. His innovative approach has the potential to impact various therapeutic applications.
Latest Patents
Donghan Lee holds a patent for a method of increasing platelet counts in a subject. This method involves administering a therapeutically effective amount of a compound that inhibits Biliverdin reductase B (BLVRB) activity. The compound works by blocking a binding site of BLVRB or utilizing a pharmaceutically acceptable salt thereof, ensuring that it does not contain xanthene or acridine moiety. This patent highlights his commitment to advancing medical treatments.
Career Highlights
Throughout his career, Donghan Lee has worked with esteemed organizations such as the Korea Basic Science Institute and the University of Louisville Research Foundation, Inc. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research endeavors.
Collaborations
Donghan Lee has collaborated with notable colleagues, including Kyoung-Seok Ryu and Myeongkyu Kim. These partnerships have contributed to the advancement of his research and the development of innovative solutions in medical science.
Conclusion
Donghan Lee's contributions to the field of medical science through his patent and collaborations demonstrate his dedication to innovation. His work has the potential to significantly impact therapeutic practices and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile